Publications
161
Citations
2,198
Est. group size
~11
Recurring co-author estimate
Active years
59
Publishing since 1968
This researcher works on public health and health policy topics, including food environment regulation, diabetes management and prevention, and economic evaluation of health interventions in Australia. The bibliographic record also shows a cluster of pharmacology-related supplementary materials on drug metabolism, though it's unclear how this connects to the broader public health work. Overall, the research combines health economics, health services research, and food/nutrition policy with an applied, Australia-focused public health lens.
Publication counts were modest and fairly steady from 2017-2022, spiked sharply in 2023 (largely due to a batch of supplementary data files from a single study), and have since dropped to a low, irregular output through 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Digital chameleons of the food environment: an exploratory analysis of the shapeshifting nature of dark kitchens in Australia and their regulatory challenges
Research Square · 2026
- A Case Study of Changes in the Healthiness, Equity, and Environmental Sustainability of an Australian University Food Environment: Findings from Two Audits Using the Uni-Food Tool (2022–2025)
Sustainability · 2026
- Improving allied health service use for type 2 diabetes management in Australia: a scoping review of barriers, enablers and policy opportunities
Public Health Research & Practice · 2026
- P3.01.24 Economic Burden of Radon Attributable Non-Small Cell Lung Cancer: A Cost Analysis
Journal of Thoracic Oncology · 2025
- Economic evaluation of a mobile phone text-message intervention for Australian adults with type 2 diabetes
mHealth · 2023
- Supplementary Table 1 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Methods from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 7 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 2 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 5 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 4 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 6 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 1 from Ontogeny and Sorafenib Metabolism
2023
- Supplementary Figure 3 from Ontogeny and Sorafenib Metabolism
2023
- Data from Ontogeny and Sorafenib Metabolism
2023
- The FASEB Journal×9
- Cancer Research×3
- Pharmaceutics×3
- Journal of Clinical Investigation×2
- British Journal of Cancer×2
- Shuiying Hu
Medicine · The Ohio State University
- Alex Sparreboom
Medicine · The Ohio State University
- Deanna L. Kroetz
Medicine · The Ohio State University
- Christine A. Hrycyna
Medicine · Purdue University West Lafayette
- Brian Middleton
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile